Neonatal haemoglobinopathy screening in Burkina Faso: Table 1
- 22 December 2008
- journal article
- Published by BMJ in Journal of Clinical Pathology
- Vol. 62 (1) , 39-41
Abstract
Aims: To report our experience of neonatal screening for sickle cell disease in Ouagadougou (Burkina Faso) and to discuss the feasibility of neonatal screening in this country. Methods: Between the years 2000 and 2004, there were about 2341 births in five maternity services in Ouagadougou. These babies were screened for sickle cell disease in a universal screening pilot programme. In 2006, 53 babies born to selected couples were screened. The specimens were collected either by cord blood sampling or from a dried blood spot on filter paper. The screening was performed using an isoelectric focusing technique. Results: In the first stage (2000–4), the incidence of sickle cell disease was 1:57. In the second stage, six of 53 babies of selected couples were found to have major haemoglobinopathies: one was homozygous for haemoglobin S and five were compound heterozygotes for haemoglobins S and C. Conclusions: The results suggest that a national screening programme should be implemented in Burkina Faso with effective newborn and subsequent follow-up, but a methodology needs to be developed.Keywords
This publication has 4 references indexed in Scilit:
- Neonatal screening for sickle cell disorders in Ouagadougou, Burkina Faso: a pilot studyJournal of Medical Screening, 2005
- Sickle-cell diseaseThe Lancet, 2004
- The lower susceptibility to Plasmpdium falciparum malaria of Fulani of Burkina Faso (West Africa) is associated with low frequencies of classic malaria-resistance genesTransactions of the Royal Society of Tropical Medicine and Hygiene, 2001
- Hemoglobins S and C in Upper VoltaHuman Genetics, 1984